Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Jami A. Kinnucan"'
Autor:
Edward V Loftus, Daniel C Baumgart, Krisztina Gecse, Jami A Kinnucan, Susan B Connelly, Leonardo Salese, Chinyu Su, Kenneth K Kwok, John C Woolcott, Alessandro Armuzzi
Publikováno v:
Inflammatory Bowel Diseases. 29:744-751
Background Tofacitinib is an oral, small molecule Janus kinase inhibitor for the treatment of ulcerative colitis (UC). Patients with inflammatory bowel disease are susceptible to Clostridium difficile infection (CDI). Here, we evaluate CDI in the tof
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d1e25a450b042936eeff88a08da0d70a
https://doi.org/10.1093/ibd/izac139
https://doi.org/10.1093/ibd/izac139
Publikováno v:
Inflammatory Bowel Diseases.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0d81a6e6bbacfd559b5d098369aa765d
https://doi.org/10.1093/ibd/izad088
https://doi.org/10.1093/ibd/izad088
Publikováno v:
American Journal of Gastroenterology.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::743144f1570923fb2a5ff664f41a643d
https://doi.org/10.14309/ajg.0000000000002254
https://doi.org/10.14309/ajg.0000000000002254
Autor:
Marla C Dubinsky, Fernando Magro, Flavio Steinwurz, David P Hudesman, Jami A Kinnucan, Ryan C Ungaro, Markus F Neurath, Nicole Kulisek, Jerome Paulissen, Chinyu Su, Dario Ponce de Leon, Miguel Regueiro
Publikováno v:
Inflammatory bowel diseases. 29(1)
Background Tofacitinib is an oral, small molecule JAK inhibitor for the treatment of ulcerative colitis (UC). These post hoc analyses assessed associations between C-reactive protein (CRP), partial Mayo score (PMS), and efficacy outcomes during tofac
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f095cb872f56735ba8ca746205ec52ea
https://pubmed.ncbi.nlm.nih.gov/35380664
https://pubmed.ncbi.nlm.nih.gov/35380664
Publikováno v:
Gastroenterologyhepatology. 9(11)
Sleep disturbances are associated with a greater risk of serious adverse health events, economic consequences, and, most importantly, increased all-cause mortality. Several studies support the associations among sleep, immune function, and inflammati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::a1f742bdbd2cf01db15ab1b3a92ef66d
https://pubmed.ncbi.nlm.nih.gov/24764789
https://pubmed.ncbi.nlm.nih.gov/24764789